[1] Liu LB, Li M, Gao N, Shen JY, Sheng ZY, Fan DY, et al. Epidemiological and clinical characteristics of the chikungunya outbreak in Ruili City, Yunnan Province, China. J Med Virol 2022;94(2):499 − 506. https://doi.org/10.1002/jmv.27302.
[2] Zhu XX, Wang SW, Li YF, Cao Y, Su XM, Zhao XT. Epidemiological characterization of dengue fever — Yunnan province, China, 2010-2021. China CDC Wkly 2024;6(20):457 − 62. https://doi.org/10.46234/ccdcw2024.088.
[3] Li L, Li Y, Lu SF, Dong J, Xu HX, Zhang Q, et al. Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province. BMC Infect Dis 2021;21(1):104. https://doi.org/10.1186/s12879-021-05810-8.
[4] Munoz-Jordan JL. Diagnosis of Zika virus infections: challenges and opportunities. J Infect Dis 2017;216(suppl_10):S951 − 6. https://doi.org/10.1093/infdis/jix502.
[5] Asia Pacific Blood Network (APBN). Dengue and the blood supply. White paper updated January 2019. https://asiapacificbloodnetwork.org/wp-content/uploads/2023/03/apbn_white_paper_dengue_v2019_final.pdf. [2024-7-29].
[6] Guzman MG, Harris E. Dengue. Lancet 2015;385(9966):453 − 65. https://doi.org/10.1016/S0140-6736(14)60572-9.
[7] Viennet E, Frentiu FD, Williams CR, Mincham G, Jansen CC, Montgomery BL, et al. Estimation of mosquito-borne and sexual transmission of Zika virus in Australia: risks to blood transfusion safety. PLoS Negl Trop Dis 2020;14(7):e0008438. https://doi.org/10.1371/journal.pntd.0008438.
[8] Giménez-Richarte Á, Ortiz de Salazar M, Arbona C, Giménez-Richarte MP, Collado M, Fernández PL, et al. Prevalence of Chikungunya, Dengue and Zika viruses in blood donors: a systematic literature review and meta-analysis. Blood Transfus 2022;20(4):267 − 80. https://doi.org/10.2450/2021.0106-21.
[9] World Health Organization. Global arbovirus initiative: preparing for the next pandemic by tackling mosquito-borne viruses with epidemic and pandemic potential. World Health Organization. https://www.who.int/publications/i/item/9789240088948. [2024-5-13].